1
Clinical Trials associated with Autologous bone marrow stem cell(Manipal Acunova)Phase II Intravenous Autologous Bone Marrow-derived Stem Cells Therapy for Patients With Acute Ischemic Stroke
A multi-centric initiative to study safety,feasibility and efficacy of using intravenous autologous bone marrow mononuclear cells(BMMC) in patients with acute ischemic stroke.This phase of study is visualised as phase 2 study and will aim to determine dose response gradient of stem cell therapy and to explore if there is favorable risk to benefit ratio for autologous stem cell therapy in patient with acute ischamic stroke.
100 Clinical Results associated with Autologous bone marrow stem cell(Manipal Acunova)
100 Translational Medicine associated with Autologous bone marrow stem cell(Manipal Acunova)
100 Patents (Medical) associated with Autologous bone marrow stem cell(Manipal Acunova)
100 Deals associated with Autologous bone marrow stem cell(Manipal Acunova)